Rob Chess

Chess is the former CEO and current chairman of Nektar Therapeutics. He currently serves on the board of Twist Biosciences and lectures at Stanford’s Graduate School of Business. He co-founded Riota Technologies, a pioneer of DNA sequencing for energy and industrial applications, Penederm, (acquired by Mylan Laboratores), and was the first CEO of OPX Biotechnologies, a nenewable chemicals company sold to Cargill.

  • October 2022

Added to: BigHat Biosciences - San Mateo, CA

BigHat Biosciences is an early-stage biotechnology company.